New Trends in Developing Therapeutic Proteins by Synthetic Cells on Diseased Tissues

New Trends in Developing Therapeutic Proteins by Synthetic Cells on Diseased Tissues

Chittipolu Ajaykumar (Vision College of Pharmaceutical Sciences, Jawaharlal Nehru Technological University, India), Ravinder Doneti (Osmania University, India), Pasha Akbar (Osmania University, India), and Venkata Satya Sai Nagasri Abhishek Chembuli (Northeastern University, USA)
DOI: 10.4018/978-1-6684-6577-6.ch008
OnDemand:
(Individual Chapters)
Available
$37.50
No Current Special Offers
TOTAL SAVINGS: $37.50

Abstract

A number of disorders can be treated promisingly with therapeutic proteins. Pharmaceutical corporations are focused on protein-based research in their pursuit for cutting-edge, efficient treatments. The manufacturing and application of therapeutic proteins have recently advanced significantly as a consequence of the enormous attention given by researchers. Biotechnological developments have accelerated and streamlined the manufacturing of therapeutically important proteins to fight a variety of terminal illnesses. Although protein-based treatments have assumed a prominent role in drug research and development and improved human safety, a number of difficulties still exist, including problems with safety, protein stability, and immunogenicity and degradation. The authors made an effort to address all potential contributing aspects to the creation of therapeutic proteins as well as any obstacles that researchers may be facing at the moment.
Chapter Preview
Top

Types Of Therapeutic Proteins

The proteins and peptides have known for several properties they differ in certain features such as length of polymers, the count of amino acids were <50 in case of peptides but the minimum chain length were found to be >100 amino acids.

Complete Chapter List

Search this Book:
Reset